Last updated: 2026-09-16 13:20:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Icon Plc (ICLR) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $172.65, with a market capitalisation of $13.03B and a P/E ratio of 39.39. Over the past 52 weeks, its price has ranged from $66.57 to $203.91. This page covers its latest market performance, valuation, price trends and company information.
$13.03B | |
$172.59 | |
$347.72 | |
$0.03 | |
$172.45 | |
1.48K | |
825.82K | |
39.39 | |
$203.91 | |
$66.57 | |
-- | |
-- |
Icon Plc (ICLR) is trading at $172.65 in pre-market trading as of 2026-09-16 13:13:00, up 0.11% ($0.20) from the previous close of $172.45
Pre-market trading shows how investors are pricing ICLR before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Icon Plc (ICLR) moved from $164.85 to $172.65, representing a gain of 4.73% ($7.80).
The stock traded between $156.70 and $180.41 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.08 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 77.2%
ICLR is currently trading at $172.65, placing it 77.2% of the way from its 52-week low of $66.57 to its 52-week high of $203.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
| Employees | 40100 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Icon Plc (ICLR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.